Akash Maniam, Medical Oncologist at Portsmouth Hospitals University NHS Trust, shared a post by JAMA Oncology on LinkedIn:
“Excellent analysis in an increasingly relevant and important field.”
Quoting JAMA Oncology’s post:
“Most viewed in the last 7 days from JAMA Oncology: Are androgen receptor signaling inhibitors associated with increased risk of CV events in men with advanced and metastatic prostate cancer?”
Visit the article website.
Source: Akash Maniam/LinkedIn and JAMA Oncology/LinkedIn